What to watch with APOE and menopause?

For women with APOE variants (especially ε4) entering menopause, key watchpoints include the interaction between estrogen decline and genetic predisposition. Estrogen has protective effects on cardiovascular and cognitive health; its drop during menopause may amplify APOE4-associated risks for Alzheimer's disease and elevated LDL cholesterol. Recommended monitoring: regular lipid panels (LDL, HDL, triglycerides), blood pressure, and cognitive function. Lifestyle interventions (Mediterranean diet, aerobic exercise, stress management) are strongly supported. Hormone replacement therapy (HRT) remains controversial: some evidence suggests benefit if started early in menopause, but risks (thrombosis, breast cancer) must be weighed. Evidence level: moderate – based on observational studies and mechanistic data, but no large randomized trials specifically for APOE carriers. Caveat: Direct-to-consumer APOE testing often lacks genetic counseling; results can cause unnecessary anxiety or false reassurance. Always discuss with a healthcare provider familiar with menopause and genetics.